[Efficacy and safety analysis of BTK inhibitors combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma].

PubMed 2026 Open access

Read full text

Authors: J B Lu, L Cao, H L Liu, Y. Miao, H R Shen, Y Xia, Hua Yin, Y X Cheng, J Y Li, L Fan

DOI: 10.3760/cma.j.cn121090-20250811-00375

Cited by: 1

Abstract

BTKi combined with R-CHOP significantly improved response rates and survival in patients with DE-DLBCL, with manageable safety.